Erlotinib D6 (Synonyms: CP-358774-d6; NSC 718781-d6; OSI-774-d6) |
Katalog-Nr.GC60154 |
Erlotinib D6 (CP-358774 D6) ist ein Deuterium-markiertes Erlotinib (CP-358774). Erlotinib ist ein direkt wirkender EGFR-Tyrosinkinase-Hemmer mit einem IC50-Wert von 2 nM für humanen EGFR.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1034651-23-4
Sample solution is provided at 25 µL, 10mM.
Erlotinib D6 (CP-358774 D6) is a deuterium labeled Erlotinib (CP-358774). Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR[1].
[1]. Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997, 57(21), 4838-4848.
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *